Patents Assigned to NeoPro Labs, LLC
  • Methods and Compositions for Treating Conditions
    Publication number: 20140047580
    Abstract: The invention relates to compositions comprising of SEQ NO: 1-244, 248-249, and any homologs, analogs, and fragments thereof. Such compositions can be used to treat, prevent, and modulate pain, inflammation, and metabolic processes in various organisms including plants and animals. Such compositions can be formulated with an acceptable pharmaceutical excipient for administration to a human or a plant. The compositions can be administered topically or for systemic use.
    Type: Application
    Filed: July 29, 2013
    Publication date: February 13, 2014
    Applicant: NeoPro Labs, LLC.
    Inventor: Hanna Skubatch
  • Methods and compositions for treating conditions
    Patent number: 8530432
    Abstract: The invention relates to compositions comprising of SEQ NO: 1-244, 248-249, and any homologs, analogs, and fragments thereof. Such compositions can be used to treat, prevent, and modulate pain, inflammation, and metabolic processes in various organisms including plants and animals. Such compositions can be formulated with an acceptable pharmaceutical excipient for administration to a human or a plant. The compositions can be administered topically or for systemic use.
    Type: Grant
    Filed: October 20, 2009
    Date of Patent: September 10, 2013
    Assignee: NeoPro Labs, LLC
    Inventor: Hanna Skubatch
  • Crystalline and amorphous forms of peptide
    Patent number: 8217141
    Abstract: The present invention relates to the crystalline and amorphous structures of SEQ ID NO:1 (FLPS), methods of making the same and use in treatment of various diseases and conditions.
    Type: Grant
    Filed: May 19, 2008
    Date of Patent: July 10, 2012
    Assignee: Neopro Labs, LLC
    Inventor: Hanna Skubatch
  • METHODS AND COMPOSITIONS FOR TREATING CONDITIONS
    Publication number: 20110190138
    Abstract: The invention relates to compositions comprising of SEQ NO: 1-244, 248-249, and any homologs, analogs, and fragments thereof. Such compositions can be used to treat, prevent, and modulate pain, inflammation, and metabolic processes in various organisms including plants and animals. Such compositions can be formulated with an acceptable pharmaceutical excipient for administration to a human or a plant. The compositions can be administered topically or for systemic use.
    Type: Application
    Filed: January 24, 2011
    Publication date: August 4, 2011
    Applicant: NeoPro Labs LLC
    Inventor: Hanna Skubatch
  • Method of treating condition in animal
    Patent number: 7858586
    Abstract: The invention relates to compositions comprising of SEQ NO: 1-244, 248-249, and any homologs, analogs, and fragments thereof. Such compositions can be used to treat, prevent, and modulate pain, inflammation, and metabolic processes in various organisms including plants and animals. Such compositions can be formulated with an acceptable pharmaceutical excipient for administration to a human or a plant. The compositions can be administered topically or for systemic use.
    Type: Grant
    Filed: March 2, 2007
    Date of Patent: December 28, 2010
    Assignee: NeoPro Labs, LLC
    Inventor: Hanna Skubatch
  • Methods for modulating activities in plants
    Patent number: 7851448
    Abstract: The invention relates to methods for modulating, treating and preventing conditions in seeds and plants. The methods include the use of a composition comprising SEQ ID NO: 1, optionally with one or two conservative substitutions or a nucleic acid of the above.
    Type: Grant
    Filed: March 2, 2007
    Date of Patent: December 14, 2010
    Assignee: NeoPro Labs, LLC
    Inventor: Hanna Skubatch
  • Methods and compositions for treating conditions
    Patent number: 7557088
    Abstract: The invention relates to compositions that can be used to treat, prevent, and modulate pain, inflammation, and metabolic processes in various organisms including plants and animals. Such compositions can be formulated with an acceptable pharmaceutical excipient for administration to a human or a plant. The compositions can be administered topically or for systemic use.
    Type: Grant
    Filed: March 28, 2007
    Date of Patent: July 7, 2009
    Assignee: NeoPro Labs, LLC
    Inventor: Hanna Skubatch